NIAAA Natural History Protocol for Alcohol Use
This observational study aims to better understand alcohol problems by gathering information from people with and without alcohol use disorder (AUD). Researchers will collect a wide range of information, including clinical details, behaviors, and genetic data, from adults aged 18 to 100. This includes individuals seeking treatment for AUD, those who are not seeking treatment, and healthy volunteers. The goal is to create a comprehensive dataset that will help scientists explore the impact of alcohol use on overall health and identify potential candidates for future research studies. This study does not involve any specific interventions or treatments.
- Study design
- This is an observational study with a planned enrollment of 7500 participants. It is designed to collect a broad range of information across the alcohol use spectrum.
- What's involved
- Participants will complete the study, including genetic and MRI tests. A standard set of data will be collected.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint involves obtaining phenotypic assessments measured at a single point in time (cross-sectional).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NIAAA Natural History Protocol
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Nancy Diazgranados, M.D. · PRINCIPAL_INVESTIGATOR · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Obtain phenotypic assessmentsCROSS SECTIONAL
To gather characterization measures for individuals wishing to participate in this protocol, including a standardized set of clinical, behavioral, biochemical, and structural MRI-based phenotypic assessments, as well as whole genome genotypes